Inverness Strengthens R&D Pipeline Through Wampole Labs IP Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Inverness Medical Innovations' purchase of Wampole Laboratories bolsters its immunoassay intellectual property position and gives the firm a distribution presence in labs and physician offices